
Agnieszka Boesen
Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1050 |
| Issued Applications | 614 |
| Pending Applications | 117 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7116221
[patent_doc_number] => 20050069522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Combination pharmaceutical agents as inhibitors of HCV replication'
[patent_app_type] => utility
[patent_app_number] => 10/637156
[patent_app_country] => US
[patent_app_date] => 2003-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21311
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20050069522.pdf
[firstpage_image] =>[orig_patent_app_number] => 10637156
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/637156 | Combination pharmaceutical agents as inhibitors of HCV replication | Aug 7, 2003 | Abandoned |
Array
(
[id] => 428774
[patent_doc_number] => 07268209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-11
[patent_title] => 'Peptides, derivates thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/632949
[patent_app_country] => US
[patent_app_date] => 2003-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 13197
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/268/07268209.pdf
[firstpage_image] =>[orig_patent_app_number] => 10632949
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/632949 | Peptides, derivates thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient | Jul 30, 2003 | Issued |
Array
(
[id] => 5252806
[patent_doc_number] => 20070134262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Antigens encoded by alternative reading frames from pathogenic viruses'
[patent_app_type] => utility
[patent_app_number] => 10/512790
[patent_app_country] => US
[patent_app_date] => 2003-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 109006
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134262.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512790 | Antigens encoded by alternative reading frames from pathogenic viruses | Jul 23, 2003 | Issued |
Array
(
[id] => 7164883
[patent_doc_number] => 20040076645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Ghrelin-carrier conjugates'
[patent_app_type] => new
[patent_app_number] => 10/622124
[patent_app_country] => US
[patent_app_date] => 2003-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35236
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20040076645.pdf
[firstpage_image] =>[orig_patent_app_number] => 10622124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/622124 | Ghrelin-carrier conjugates | Jul 17, 2003 | Abandoned |
Array
(
[id] => 7082702
[patent_doc_number] => 20050048082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Adjuvant viral particle'
[patent_app_type] => utility
[patent_app_number] => 10/609417
[patent_app_country] => US
[patent_app_date] => 2003-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6772
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048082.pdf
[firstpage_image] =>[orig_patent_app_number] => 10609417
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/609417 | Adjuvant viral particle | Jun 30, 2003 | Issued |
Array
(
[id] => 5858684
[patent_doc_number] => 20060228696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Methods for detecting and inactivating a prion'
[patent_app_type] => utility
[patent_app_number] => 10/520785
[patent_app_country] => US
[patent_app_date] => 2003-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7595
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228696.pdf
[firstpage_image] =>[orig_patent_app_number] => 10520785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/520785 | Methods for detecting and inactivating a prion | Jun 26, 2003 | Abandoned |
Array
(
[id] => 7199522
[patent_doc_number] => 20040086517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Method of modulating the immune system in an animal to an antigen'
[patent_app_type] => new
[patent_app_number] => 10/602924
[patent_app_country] => US
[patent_app_date] => 2003-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9713
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086517.pdf
[firstpage_image] =>[orig_patent_app_number] => 10602924
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/602924 | Method of modulating the immune system in an animal to an antigen | Jun 23, 2003 | Abandoned |
Array
(
[id] => 7230445
[patent_doc_number] => 20040156862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Novel hepatitis C virus peptides and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/601020
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14358
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20040156862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10601020
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/601020 | Hepatitis C virus peptides and uses thereof | Jun 19, 2003 | Issued |
Array
(
[id] => 6912228
[patent_doc_number] => 20050175986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Human monoclonal antibody'
[patent_app_type] => utility
[patent_app_number] => 10/461576
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 13676
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175986.pdf
[firstpage_image] =>[orig_patent_app_number] => 10461576
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/461576 | Human monoclonal antibody | Jun 12, 2003 | Abandoned |
Array
(
[id] => 7425022
[patent_doc_number] => 20040208919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Vaccination against prion diseases'
[patent_app_type] => new
[patent_app_number] => 10/461864
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6180
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208919.pdf
[firstpage_image] =>[orig_patent_app_number] => 10461864
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/461864 | Vaccination against prion diseases | Jun 12, 2003 | Abandoned |
Array
(
[id] => 7136663
[patent_doc_number] => 20040044185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Membrane fusion proteins derived from reovirus'
[patent_app_type] => new
[patent_app_number] => 10/433276
[patent_app_country] => US
[patent_app_date] => 2003-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13821
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20040044185.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433276
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433276 | Membrane fusion proteins derived from reovirus | Jun 1, 2003 | Abandoned |
Array
(
[id] => 7269796
[patent_doc_number] => 20040058314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Assay for the detection and quantification of HBV cccDNA by real-time PCR'
[patent_app_type] => new
[patent_app_number] => 10/449801
[patent_app_country] => US
[patent_app_date] => 2003-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5638
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10449801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/449801 | Assay for the detection and quantification of HBV cccDNA by real-time PCR | May 28, 2003 | Abandoned |
Array
(
[id] => 5843293
[patent_doc_number] => 20060121531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Piezoelectric bio-chip for detecting pathogen of mad cow disease and thereon preparation'
[patent_app_type] => utility
[patent_app_number] => 10/523174
[patent_app_country] => US
[patent_app_date] => 2003-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3225
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121531.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523174
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523174 | Piezoelectric bio-chip for detecting pathogen of mad cow disease and thereon preparation | May 21, 2003 | Abandoned |
Array
(
[id] => 6701137
[patent_doc_number] => 20030224017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Recombinant Newcastle disease viruses useful as vaccines or vaccine vectors'
[patent_app_type] => new
[patent_app_number] => 10/440419
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 9857
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10440419
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/440419 | Recombinant Newcastle disease viruses useful as vaccines or vaccine vectors | May 18, 2003 | Abandoned |
Array
(
[id] => 5743184
[patent_doc_number] => 20060088909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Virus-like particles, methods of preparation, and immunogenic compositions'
[patent_app_type] => utility
[patent_app_number] => 10/514462
[patent_app_country] => US
[patent_app_date] => 2003-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13081
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20060088909.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514462
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514462 | Virus-like particles, methods of preparation, and immunogenic compositions | May 18, 2003 | Abandoned |
Array
(
[id] => 7351272
[patent_doc_number] => 20040048237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Mammalian prion proteins and transgenic mice expressing them'
[patent_app_type] => new
[patent_app_number] => 10/438628
[patent_app_country] => US
[patent_app_date] => 2003-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13138
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10438628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/438628 | Mammalian prion proteins and transgenic mice expressing them | May 14, 2003 | Abandoned |
Array
(
[id] => 7220693
[patent_doc_number] => 20040072267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Method for simultaneously detecting an antigen of, and and antibody against, an infectious microorganism'
[patent_app_type] => new
[patent_app_number] => 10/431587
[patent_app_country] => US
[patent_app_date] => 2003-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18081
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072267.pdf
[firstpage_image] =>[orig_patent_app_number] => 10431587
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/431587 | Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism | May 7, 2003 | Issued |
Array
(
[id] => 7295877
[patent_doc_number] => 20040214178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Reporter-selectable Hepatitis C virus replicon'
[patent_app_type] => new
[patent_app_number] => 10/422323
[patent_app_country] => US
[patent_app_date] => 2003-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11041
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214178.pdf
[firstpage_image] =>[orig_patent_app_number] => 10422323
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/422323 | Reporter-selectable Hepatitis C virus replicon | Apr 23, 2003 | Abandoned |
Array
(
[id] => 6821571
[patent_doc_number] => 20030219732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Adaptation sites of porcine reproductive and respiratory syndrome virus'
[patent_app_type] => new
[patent_app_number] => 10/407822
[patent_app_country] => US
[patent_app_date] => 2003-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6279
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219732.pdf
[firstpage_image] =>[orig_patent_app_number] => 10407822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/407822 | Adaptation sites of porcine reproductive and respiratory syndrome virus | Apr 3, 2003 | Issued |
Array
(
[id] => 6769977
[patent_doc_number] => 20030215917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Assay for evaluation of activity of compounds against HCV using a novel detection system in the HCV replicon'
[patent_app_type] => new
[patent_app_number] => 10/407066
[patent_app_country] => US
[patent_app_date] => 2003-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12481
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215917.pdf
[firstpage_image] =>[orig_patent_app_number] => 10407066
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/407066 | Assay for evaluation of activity of compounds against HCV using a novel detection system in the HCV replicon | Apr 2, 2003 | Abandoned |